In-Depth Notes on Drug Addiction and Its Impact

Drug abuse has garnered significant media attention, particularly concerning opioids.
Opioid abuse can lead to overdose and death, with Cincinnati reporting 174 overdose cases in one week in 2017.
The U.S. spends approximately $700 billion annually on addiction-related issues.

Addiction is defined as a chronic brain disorder characterized by physical and psychological dependence on substances.
Key Characteristics of Addiction:
- Users lose the ability to control substance use despite adverse consequences.
- Tolerance: The body requires increased amounts of a drug for the same effect.
- Withdrawal: Discontinuing a drug can lead to severe physical symptoms (headaches to seizures).
Factors in Addiction:
- A mix of positive reinforcements (pleasurable feelings) and negative reinforcements (avoiding withdrawal symptoms).
- Cues or triggers can provoke drug-taking behavior (e.g., locations associated with past drug use).

Almost all abused drugs stimulate the brain's reward system, primarily involving the neurotransmitter dopamine.
The Limbic System:
- Regulates emotions and healthy behaviors like eating.
- Also activated by drugs, leading to addictive behaviors.
Drugs can mimic or inhibit neurotransmitters, altering how the brain functions and affects judgment and decision-making.

Genetic Vulnerability: Approximately 50% of addiction risk may stem from genetic factors.
Environmental Factors: Stress and social settings contribute to addiction development; these factors interact with an individual's genetic background.
Biological differences are noted between genders, affecting the risk of addiction and treatment response.

First used in prehistoric times, opioids (e.g., morphine, heroin) act quickly on the brain's opioid receptors, inducing euphoria.
Fentanyl, a powerful synthetic opioid, has surged in use and danger.
The opioid addiction crisis largely emanated from increased prescription practices starting in the mid-1980s.

Naloxone: An opioid antagonist used for overdose reversal; can block opioid effects if administered quickly.
Methadone & Buprenorphine: Medications that stabilize patients by mimicking opioid effects without intense highs; buprenorphine is regarded as safer.
Psychosocial Treatments: Cognitive behavioral therapy to address the psychological aspects of addiction.

Nicotine activates nicotinic acetylcholine receptors to release neurotransmitters, generating feelings of pleasure.
Tobacco is a major contributor to preventable deaths, yet 20% of Americans still smoke.
Nicotine generates tolerance and dependence, leading to higher usage over time.

Options include nicotine replacement therapies (gum, patches, etc.) and medications like varenicline, which acts on nicotine receptors.
Behavioral therapies enhance treatment effectiveness when combined with pharmacotherapy.

Ethanol, the active component in alcoholic beverages, poses serious addiction risks and can cause liver damage.
Alcohol's effects fluctuate from stimulant to depressant depending on consumption levels.

Risks are influenced by genetics and environment, with behavioral therapies and medications available for treatment.
Immediate counseling and medication (e.g., disulfiram, naltrexone) can aid in overcoming addiction.

Contains THC, which alters perception and can lead to addiction.
Regular use can affect brain neurobiology, leading to cognitive impairments.
Cannabidiol (CBD), a non-psychoactive component, holds potential therapeutic benefits.

Stimulants like caffeine and nicotine enhance mental function but carry addiction risks, especially in prescription medications used illicitly (e.g., Adderall, Ritalin).
Psychostimulants flood the brain with dopamine, leading to heightened addiction potential and physical health issues.
Cognitive behavioral therapy is the primary treatment, with ongoing research into pharmacological interventions.

These are synthetically manufactured substances that often evade legal restrictions (
"bath salts," "spice," MDMA).
Many have harmful effects on neurobiology, with the potential for long-lasting brain damage.
Some hold promise in therapeutic settings (e.g., ketamine for depression).